Department of Biomedical Sciences, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR, People's Republic of China; Key Laboratory of Biochip Technology, Biotech and Health Centre, Shenzhen Research Institutes of City University of Hong Kong, Shenzhen, People's Republic of China.
Key Laboratory of Sensing Technology and Biomedical Instruments (Guangdong Province), School of Engineering, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Anal Chim Acta. 2018 Dec 31;1044:29-65. doi: 10.1016/j.aca.2018.06.054. Epub 2018 Jun 26.
The pivotal role of microfluidic technology in life science and biomedical research is now widely recognized. Indeed, microfluidics as a research tool is unparalleled in terms of its biocompatibility, robustness, efficient reagent consumption, and controlled fluidic, surface, and structure environments. The controlled environments are essential in assessing the complex behavior of cells in response to microenvironmental cues. The strengths of microfluidics also reside in its amenability to integration with other analytical platforms and its capacity for miniaturization, parallelization and automation of biochemical assays. Following previous review on the applications of microfluidic devices for cell-based assays in 2006, we have monitored the progress in the field and summarized the advances in microfluidic technology from 2007 to 2017, with a focus on microfluidics development for applications in cell manipulation, cell capture and detection, and cell treatment and analysis. Moreover, we highlighted novel commercial microfluidic products for biomedical and clinical purposes that were introduced in the review period. Thus, this review provides a comprehensive source for recent developments in microfluidics and presents a snapshot of its remarkable contribution towards basic biomedical research and clinical science. We recognize that although enormous amounts of evidence have reinforced the promise of microfluidic technology across diverse applications, much remains to be done to realize its full potential in mainstream biomedical science and clinical practice.
微流控技术在生命科学和生物医学研究中的关键作用现在已得到广泛认可。事实上,微流控作为一种研究工具,其生物相容性、稳健性、高效试剂消耗以及对流体、表面和结构环境的控制能力是无与伦比的。这种可控环境对于评估细胞对微环境信号的复杂反应行为至关重要。微流控的优势还在于它易于与其他分析平台集成,以及能够对生化分析进行小型化、并行化和自动化。在 2006 年对微流控设备在基于细胞的分析中的应用进行了综述之后,我们一直在监测该领域的进展,并总结了 2007 年至 2017 年微流控技术的进展,重点介绍了用于细胞操作、细胞捕获和检测以及细胞处理和分析的微流控技术的发展。此外,我们还强调了在综述期间介绍的用于生物医学和临床用途的新型商业微流控产品。因此,本综述为微流控技术的最新发展提供了一个全面的资源,并展示了它在基础生物医学研究和临床科学方面的显著贡献。我们认识到,尽管大量证据已经证明了微流控技术在各种应用中的巨大潜力,但要在主流生物医学科学和临床实践中充分发挥其潜力,仍有许多工作要做。